Two Studies on Developing Safer Opioids
If you have been reading this blog for a while, you know is that I often rant about the hysteria of the war on opioids and how it often leaves people in pain untreated.There is some good news on the research front. Two new studies show promise for the development of opioids that have no addictive properties, and significantly less side effects, which would make them a safer way to treat high levels of pain. I wrote about the studies in my new HealthCentral post:
"The concerns about the safety of opioids and their potential for addiction mean that people who live with pain are facing increasing restrictions on their ability to access these medications. Earlier this year, the Centers for Disease Control and Prevention (CDC) released guidelines recommending that doctors avoid prescribing opioids for chronic pain. Drug abuse is a legitimate problem. But these kinds of restrictions end up meaning individuals with chronic pain are increasingly being left untreated.
To solve that problem, the development of a new opioid offers hope for the future of effective treatment of chronic pain."
You can read more about the two studies on developing a safer opioid on HealthCentral.
"The concerns about the safety of opioids and their potential for addiction mean that people who live with pain are facing increasing restrictions on their ability to access these medications. Earlier this year, the Centers for Disease Control and Prevention (CDC) released guidelines recommending that doctors avoid prescribing opioids for chronic pain. Drug abuse is a legitimate problem. But these kinds of restrictions end up meaning individuals with chronic pain are increasingly being left untreated.
To solve that problem, the development of a new opioid offers hope for the future of effective treatment of chronic pain."
You can read more about the two studies on developing a safer opioid on HealthCentral.
Comments
I am thrilled that someone is doing this kind of research. I hope sooner than later this medication comes to market. If they find the issue they will have a mega medication seller.